Graft-versus-host disease (GVHD) is an immune-mediated inflammatory disease resulting
from destruction of host tissue by donor immunoreactive cells and occurs in 30% to 70% of …

Purpose To investigate the profile of cytokines in tear fluid of patients after allogeneic stem
cell transplantation (allo-SCT) and determine their relation to the presence and …

We investigated the tear cytokine profiles in patients who underwent stem cell
transplantation (SCT) and attempted to evaluate whether tear cytokines are associated with …

This longitudinal cohort study compared ocular surface indicators in forty allogeneic
hematopoietic stem cell transplant (HSCT) subjects with twenty healthy controls at baseline …

Purpose To analyse the tear cytokine levels of patients diagnosed with ocular chronic graft-
versus-host disease (GVHD) and examine the consistency of these levels with different …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment
for hematological malignancies. Chronic graft-versus-host disease (cGVHD) is a common …

Graft-versus-host disease (GVHD) is characterized by tissue inflammation in the host
following an allogeneic hematopoietic cell transplantation (HCT). The pathophysiology is …

Purpose: The local application of antiinflammatory and immunosuppressive agents is an
effective method for the treatment of ocular graft-versus-host disease (oGVHD); however, we …

Purpose To analyze and compare the tear immunological profile in ocular GVHD (oGVHD)
patients with that in non-oGVHD patients and to correlate them with ocular surface …

Graft-versus-host disease is among the most common clinical complications following
allogeneic hematopoietic stem cell transplantation. It causes inflammation-mediated …